Sponsor Pipeline

Ipsen Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
33
Active Trials
20
Recruiting
9
Phase 3
10
Disease Areas
9
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-04 NCT06447168
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in…
Trial sites expanded: 68 -> 74 locations
2026-08-04 NCT07556913
Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor…
Recruitment opened
2026-08-04 NCT07191704
A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive…
Trial completed
2026-08-04 NCT07191704
A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive…
date change Primary completion moved earlier: 2026-07-31 -> 2026-06-03
2026-08-04 NCT07191704
A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive…
date change Completion moved earlier: 2026-07-31 -> 2026-06-03
2026-08-04 NCT07585097
A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome…
Recruitment opened
2026-08-04 NCT07585097
A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome…
Trial sites expanded: 0 -> 14 locations
2026-08-04 NCT06850038
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in…
date change Primary completion pushed: 2029-11 -> 2030-11-30
2026-08-04 NCT06850038
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in…
date change Completion pushed: 2029-11 -> 2030-11-30
Active Trials by Phase
Phase 3
8
Phase 2/3
1
Phase 2
3
Phase 1/2
6
Phase 1
1
Not specified
14
Active Trials — top 25 of 33
NCT IDTitleConditionStatus
Phase 3
NCT07427797 A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to… Moderate to Severe Glabellar Lines Recruiting
NCT07435428 A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With… Moderate to Severe Glabellar Lines Recruiting
NCT06016842 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis Primary Biliary Cholangitis (PBC) Recruiting
NCT07387549 A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With… Primary Sclerosing Cholangitis Recruiting
NCT06047444 A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of… Chronic Migraine Active, Not Recruiting
NCT06047457 A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of… Episodic Migraine Active, Not Recruiting
NCT06730061 A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis… Primary Biliary Cholangitis Active, Not Recruiting
NCT04526665 Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) Primary Biliary Cirrhosis Active, Not Recruiting
Phase 2/3
NCT07623187 A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With… Acute Myeloid Leukaemia (AML) Not Yet Recruiting
Phase 2
NCT06625060 A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic… Episodic Migraine Recruiting
NCT06937931 A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults Cervical Dystonia Recruiting
NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… Primary Sclerosing Cholangitis Active, Not Recruiting
Phase 1/2
NCT04752774 A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper… Spasticity Recruiting
NCT06833008 A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With… Advanced Solid Tumor Recruiting
NCT07213817 A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic… Locally Advanced Solid Tumor Recruiting
NCT07213830 A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics… Advanced Solid Tumor Recruiting
NCT04821089 A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate… Moderate to Severe Upper Facial Lines Active, Not Recruiting
NCT06305247 A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours Melanoma Active, Not Recruiting
Phase 1
NCT07441707 A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults… Low-grade Glioma Recruiting
Not specified
NCT07314164 Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already… Neuroendocrine Tumors Recruiting
NCT06089616 A Study to Document and to Further Describe Long-term Safety and Effectiveness of… Fibrodysplasia Ossificans Progressiva Recruiting
NCT06258902 Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety… Pregnancy Related Recruiting
NCT06447168 A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in… Primary Biliary Cholangitis Recruiting
NCT06850038 A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in… Alagille Syndrome Recruiting
NCT07185919 A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With… Progressive Familial Intrahepatic Cholestasis Recruiting
See all 33 active Ipsen trials with filters →
Disease Areas
Get alerts when Ipsen's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free